<DOC>
	<DOCNO>NCT00952653</DOCNO>
	<brief_summary>The main purpose study evaluate effect desvenlafaxine administer DVS SR pharmacokinetics midazolam healthy male female subject . The amount drug body effect drug also evaluate .</brief_summary>
	<brief_title>Study Evaluating Effect Desvenlafaxine Pharmacokinetics Midazolam</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Men nonpregnant , nonlactating woman , 18 55 year age inclusive screening . Healthy determine investigator basis medical history , physical examination , clinical laboratory test result , vital sign , 12lead electrocardiogram ( ECG ) . Nonsmoker smoker few 10 cigarette per day determine history . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 Ilbs ) . Presence history significant cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , dermatologic , hematologic , neurologic , psychiatric disease . Presence history glaucoma intraocular pressure . Any surgical medical condition may interfere absorption , distribution , metabolism , excretion investigational product . Allergy midazolam , benzodiazepine , desvenlafaxine , venlafaxine . Acute disease state ( eg , nausea , vomit , fever , diarrhea ) 7 day study day 1 . Admitted alcohol abuse history alcohol use may interfere subject 's ability comply protocol requirement . History drug abuse within 1 year study day 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>depression</keyword>
</DOC>